Descriptive baseline and cardiovascular risk profile characteristics of study patients
| MICE group (n=14) Mean (SD) or proportion | AIT group (n=17) Mean (SD) or proportion | |
| Age (y) | 69.6 (5.9) | 69.3 (9.9) |
| Height (m) | 1.6 (0.08) | 1.6 (0.05) |
| Body mass (kg) | 79.4 (14.0) | 67.2 (14.2) |
| Primary diagnosis | ||
| PTCA/stent (%) | 70.0 | 64.7 |
| CABG (%) | 10.0 | 29.4 |
| Ischaemic HD (%) | 20.0 | 0 |
| MI (%) | 0 | 5.9 |
| Beta-blockers (%) | 30 | 70.6 |
| ACE inhibitors (%) | 70 | 52.9 |
| Statins (%) | 90 | 100 |
| Marital status (% married) | 40 | 64.7 |
| Smoking status (% smokers) | 10 | 11.8 |
| Peak V̇O2 (mL kg-1 min-1) | 19.1 (5.5) | 20.2 (2.8) |
| BMI (kg/m2) | 28.0 (5.7) | 26.6 (4.2) |
| Abdominal girth (cm) | 92.9 (13.6) | 89.1 (10.7) |
| HDL-C (mmol/L) | 1.5 (0.7) | 1.4 (0.4) |
| LDL-C (mmol/L) | 1.8 (0.9) | 1.3 (0.5) |
| Triglycerides (mmol/L) | 1.6 (0.7) | 1.3 (0.5) |
| Resting systolic BP (mm Hg) | 123.0 (11.9) | 117.7 (13.1) |
| Resting diastolic BP (mm Hg) | 70.7 (7.8) | 72.2 (8.2) |
| FBG (mmol/L) | 6.0 (1.1) | 6.1 (1.3) |
| HbA1c (%) | 6.1 (0.8) | 5.8 (0.5) |
| Body fat (%) | 38.3 (7.6) | 35.3 (6.3) |
| CES-D score | 13.9 (5.3) | 11.5 (5.6) |
ACE, angiotensin converting enzyme; AIT, aerobic interval training; BMI, body mass index; BP, blood pressure; CABG, coronary artery bypass graft; CES-D, Centre for Epidemiological Studies Depression Scale; FBG, fasting blood glucose; HbA1c, glycated haemoglobin; HD, heart disease; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; MI, myocardial infarction; MICE, moderate intensity continuous exercise; Peak V̇O2, maximal oxygen consumption; PTCA, percutaneous transluminal coronary angioplasty; TIES, Tangible, Informational, and Emotional Social Support Survey.